Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma
- Resource Type
- Article
- Source
- In
European Journal of Cancer March 2023 182:77-86 - Subject
- Language
- ISSN
- 0959-8049